Marie Vercruyssen

Brussels, BRU, Belgium

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 11 publications

First-in-human experience of radiopharmaceutical therapy with [177Lu]Lu-DOTATATE in patients with advanced multiple myeloma.

First-in-human experience of radiopharmaceutical therapy with [177Lu]Lu-DOTATATE in patients with advanced multiple myeloma.

Journal: EJNMMI reports

Published: June 01, 2025

The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.

The SCARLET trial: a prospective phase II study of somatostatin receptor imaging for potential radiotheranostic application in patients with relapsing and refractory multiple myeloma.

Journal: European journal of nuclear medicine and molecular imaging

Published: March 10, 2025

Beyond Chemotherapy: Present and Future Perspectives in the Treatment of Lymphoproliferative Disorders.

Beyond Chemotherapy: Present and Future Perspectives in the Treatment of Lymphoproliferative Disorders.

Journal: Biomedicines

Published: March 27, 2024

Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.

Disturbing the Redox Balance Using Buthionine Sulfoximine Radiosensitized Somatostatin Receptor-2 Expressing Pre-Clinical Models to Peptide Receptor Radionuclide Therapy with 177Lu-DOTATATE.

Journal: Cancers

Published: March 03, 2023

HTLV-1-related adult T-cell leukemia/lymphoma: insights in early detection and management.

HTLV-1-related adult T-cell leukemia/lymphoma: insights in early detection and management.

Journal: Current opinion in oncology

Published: July 26, 2022

Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis.

Brentuximab Vedotin and Pembrolizumab Combination in Patients with Relapsed/Refractory Hodgkin Lymphoma: A Single-Centre Retrospective Analysis.

Journal: Cancers

Published: January 07, 2022

RETRACTED: Drug-Induced Thrombocytopenia.

RETRACTED: Drug-Induced Thrombocytopenia.

Journal: Clinical lymphoma, myeloma & leukemia

Published: April 14, 2020

Monoclonal gammopathy of undetermined significance : when and why to look for them ?

Monoclonal gammopathy of undetermined significance : when and why to look for them ?

Journal: Revue medicale de Bruxelles

Published: October 16, 2018

Diagnostic approach of an IgM monoclonal gammopathy and clinical importance of gene MYD88 L265P mutation

Diagnostic approach of an IgM monoclonal gammopathy and clinical importance of gene MYD88 L265P mutation

Journal: Revue medicale de Bruxelles

Published: June 06, 2018

Long-term follow-up of 2 patients treated with 90 Y-rituximab radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma.

Long-term follow-up of 2 patients treated with 90 Y-rituximab radioimmunotherapy for relapse of nodular lymphocyte-predominant Hodgkin lymphoma.

Journal: European journal of haematology

Published: March 29, 2018

Myocardial inflammation in experimental acute right ventricular failure: Effects of prostacyclin therapy.

Myocardial inflammation in experimental acute right ventricular failure: Effects of prostacyclin therapy.

Journal: The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation

Published: October 20, 2014

Showing 1-11 of 11

Last Updated: 09/26/2026